PL140363B1 - Method of obtaining new 5's-/2r-butyl/-peptidergot alkaloide - Google Patents
Method of obtaining new 5's-/2r-butyl/-peptidergot alkaloide Download PDFInfo
- Publication number
- PL140363B1 PL140363B1 PL1983240540A PL24054083A PL140363B1 PL 140363 B1 PL140363 B1 PL 140363B1 PL 1983240540 A PL1983240540 A PL 1983240540A PL 24054083 A PL24054083 A PL 24054083A PL 140363 B1 PL140363 B1 PL 140363B1
- Authority
- PL
- Poland
- Prior art keywords
- compound
- formula
- acid
- butyl
- ether
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH89382 | 1982-02-12 | ||
| CH692482 | 1982-11-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL240540A1 PL240540A1 (en) | 1984-06-18 |
| PL140363B1 true PL140363B1 (en) | 1987-04-30 |
Family
ID=25686031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1983240540A PL140363B1 (en) | 1982-02-12 | 1983-02-11 | Method of obtaining new 5's-/2r-butyl/-peptidergot alkaloide |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4737499A (enExample) |
| KR (1) | KR890000813B1 (enExample) |
| AT (1) | AT382874B (enExample) |
| AU (1) | AU564596B2 (enExample) |
| CA (1) | CA1245641A (enExample) |
| CH (1) | CH658249A5 (enExample) |
| CS (1) | CS236782B2 (enExample) |
| CY (1) | CY1432A (enExample) |
| DD (1) | DD208356A5 (enExample) |
| DE (1) | DE3303616A1 (enExample) |
| DK (1) | DK62283A (enExample) |
| ES (1) | ES8500280A1 (enExample) |
| FI (1) | FI71941C (enExample) |
| FR (1) | FR2522663B1 (enExample) |
| GB (1) | GB2114980B (enExample) |
| GR (1) | GR77417B (enExample) |
| HK (1) | HK53088A (enExample) |
| IE (1) | IE54501B1 (enExample) |
| IL (1) | IL67883A (enExample) |
| IT (1) | IT1197571B (enExample) |
| KE (1) | KE3811A (enExample) |
| MY (1) | MY8600569A (enExample) |
| NL (1) | NL8300484A (enExample) |
| NO (1) | NO164773C (enExample) |
| NZ (1) | NZ203252A (enExample) |
| PH (1) | PH21234A (enExample) |
| PL (1) | PL140363B1 (enExample) |
| PT (1) | PT76222B (enExample) |
| SE (1) | SE455097B (enExample) |
| SG (1) | SG22588G (enExample) |
| WO (1) | WO1983002775A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU571927B2 (en) * | 1979-06-12 | 1988-04-28 | Sandoz Ltd. | A 2-methyl ergot peptide alkaloid |
| HU195729B (en) * | 1985-02-05 | 1988-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides |
| US7771746B2 (en) * | 1999-12-03 | 2010-08-10 | Polichem Sa | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| US6831216B2 (en) * | 2002-05-21 | 2004-12-14 | Holden's Foundation Seeds Llc | Inbred corn line LH247 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH503031A (de) * | 1967-04-12 | 1971-02-15 | Sandoz Ag | Verfahren zur Herstellung heterocyclischer Verbindungen |
| CH520679A (de) * | 1967-08-02 | 1972-03-31 | Sandoz Ag | Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide |
| CH505102A (de) * | 1967-11-01 | 1971-03-31 | Sandoz Ag | Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide |
| DK140017B (da) * | 1973-07-09 | 1979-06-05 | Sandoz Ag | Fremgangsmåde til fremstilling af octahydro-oxazolo(3,2-a)pyrrolo(2,1-c)pyrazinderivater. |
| CH602765A5 (enExample) * | 1974-09-27 | 1978-07-31 | Sandoz Ag | |
| CH601321A5 (enExample) * | 1975-01-06 | 1978-07-14 | Sandoz Ag | |
| US4138565A (en) * | 1975-05-31 | 1979-02-06 | Sandoz Ltd. | Stable solutions and processes for their preparation |
| CH619468A5 (enExample) * | 1976-01-12 | 1980-09-30 | Sandoz Ag | |
| DE3340025C2 (de) * | 1983-11-03 | 1986-01-09 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen |
-
1983
- 1983-02-03 DE DE19833303616 patent/DE3303616A1/de not_active Withdrawn
- 1983-02-04 FI FI830399A patent/FI71941C/fi not_active IP Right Cessation
- 1983-02-08 PH PH28488A patent/PH21234A/en unknown
- 1983-02-08 GB GB08303475A patent/GB2114980B/en not_active Expired
- 1983-02-08 FR FR8302099A patent/FR2522663B1/fr not_active Expired
- 1983-02-09 NO NO830416A patent/NO164773C/no unknown
- 1983-02-09 CH CH5668/83A patent/CH658249A5/de not_active IP Right Cessation
- 1983-02-09 WO PCT/CH1983/000013 patent/WO1983002775A1/de not_active Ceased
- 1983-02-09 NL NL8300484A patent/NL8300484A/nl not_active Application Discontinuation
- 1983-02-10 IL IL67883A patent/IL67883A/xx unknown
- 1983-02-10 SE SE8300711A patent/SE455097B/sv not_active IP Right Cessation
- 1983-02-10 CS CS83925A patent/CS236782B2/cs unknown
- 1983-02-10 PT PT76222A patent/PT76222B/pt unknown
- 1983-02-10 KR KR1019830000523A patent/KR890000813B1/ko not_active Expired
- 1983-02-10 GR GR70467A patent/GR77417B/el unknown
- 1983-02-10 AU AU11292/83A patent/AU564596B2/en not_active Ceased
- 1983-02-10 ES ES519687A patent/ES8500280A1/es not_active Expired
- 1983-02-10 NZ NZ203252A patent/NZ203252A/en unknown
- 1983-02-10 CA CA000421320A patent/CA1245641A/en not_active Expired
- 1983-02-11 AT AT0047583A patent/AT382874B/de not_active IP Right Cessation
- 1983-02-11 IT IT47702/83A patent/IT1197571B/it active
- 1983-02-11 IE IE282/83A patent/IE54501B1/en unknown
- 1983-02-11 PL PL1983240540A patent/PL140363B1/pl unknown
- 1983-02-11 DK DK62283A patent/DK62283A/da not_active Application Discontinuation
- 1983-02-11 DD DD83247889A patent/DD208356A5/de not_active IP Right Cessation
-
1986
- 1986-11-18 US US06/932,075 patent/US4737499A/en not_active Expired - Fee Related
- 1986-12-30 MY MY569/86A patent/MY8600569A/xx unknown
-
1988
- 1988-04-05 SG SG225/88A patent/SG22588G/en unknown
- 1988-04-24 KE KE3811A patent/KE3811A/xx unknown
- 1988-07-14 HK HK530/88A patent/HK53088A/xx unknown
- 1988-09-02 CY CY1432A patent/CY1432A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH02300167A (ja) | 鎮痛剤として用いられるｎ―フエニル―ｎ―（４―ピペリジニル）アミド | |
| JPH01190680A (ja) | インドール誘導体およびその製造方法 | |
| US4005089A (en) | Compounds with ergoline skeleton | |
| KR900008696B1 (ko) | 에르골린 유도체의 제조방법 | |
| EP0216247A2 (en) | Use of alpha 2 adrenergic receptor antagonists for the production of pharmaceutical compositions for treating colonic spasm, irritable bowel syndrome and constipation and process for preparing such pharmaceutical compositions | |
| KR840001551B1 (ko) | 시클로헥센 유도체의 제조방법 | |
| US5366979A (en) | Orally active nonaddicting analgesics | |
| JP3160941B2 (ja) | カルバゾール誘導体および免疫抑制剤 | |
| PL140363B1 (en) | Method of obtaining new 5's-/2r-butyl/-peptidergot alkaloide | |
| EP0328700A1 (en) | 4,7-Dihydropyrazolo(1,5-a)pyrimidine compound and pharmaceutical use thereof | |
| WO1987005903A2 (en) | Orally active nonaddicting analgesics | |
| JPH06199866A (ja) | ジアゼピン誘導体 | |
| US3985752A (en) | 6-Methyl-8-(substituted) methylergolines | |
| WO1999038864A1 (en) | Oxazole derivatives as serotonin-1a receptor agonists | |
| JPH0386853A (ja) | 置換フェノール誘導体およびその用途 | |
| RU2101284C1 (ru) | Оптически активные производные карбоксамидов или их фармакологически пригодные соли, фармацевтическая композиция, обладающая анальгезирующей активностью | |
| EP0001585B1 (de) | Piperazino-pyrrolobenzodiazepine, Verfahren zu ihrer Herstellung sowie pharmazeutische Präparate enthaltend diese Verbindungen | |
| EP0254527B1 (en) | Tetracyclic indole derivatives | |
| US4064249A (en) | Compounds with ergoline skeleton | |
| JPH0352473B2 (enExample) | ||
| US5530014A (en) | Cyclohexadiene derivatives | |
| US4871765A (en) | Amine derivative and its salt and anti-ulcer agent containing the same | |
| S'kof et al. | Stereoselective Amination of 5‐Substituted γ‐Lactones and γ‐Lactams–A Convenient Route for the Preparation of 5‐Substituted (3S, 5S)‐3‐Acetylaminotetrahydrofuran‐2‐ones and (3S, 5S)‐3‐Acetylaminopyrrolidin‐2‐ones | |
| US4782063A (en) | Ergoline esters useful as serotonin antagonists | |
| US4358452A (en) | N-[1,2,3,4,6,7,12,12 α-octahydro-2H-indolo(2,3α)-quinolizinyl-2β-yl]alkane and benzyl sulfonamides and anti-hypertensive use thereof |